Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The trial confirms ALE.F02's good safety profile, exposure and target biological activity Alentis Therapeutics ("Alentis"), the clinical-stage biotechnology company developing breakthrough treatments
– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles ... | April 26, 2023
The bear onslaught on 10 technology stocks comprising the Nifty IT index wiped ₹1.03 trillion off investor wealth, with Infosys Ltd alone accounting for a little more than half of the losses
MAIA Biotechnology, Inc. today announced positive topline data from the completed Part A safety lead-in of the Company’s THIO-101 Phase 2 go-to-market trial in advanced Non-Small Cell Lung... | April 11, 2023
· REVENUES UP 15% AT €90.6 MILLION [8% LIKE-FOR-LIKE] · MONTHLY RECURRING REVENUE PROGRESS BY 25%, EXCEEDING TOTAL TOPLINE GROWTH · EBITDA OF €5.0 MILLION;... | April 6, 2023